Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prisyna is a glycopolymer-based oral care solution developed by Synedgen, designed to cleanse, moisturize, and protect the oral mucosa. It utilizes a proprietary modified chitosan-based glycopolymer technology that facilitates the physical removal of oral debris, bacteria, and biofilms while providing a protective coating to sensitive tissues. It is primarily indicated for patients experiencing dry mouth (xerostomia), oral mucositis, or general oral sensitivity, particularly those undergoing chemotherapy or radiation therapy. By maintaining a moist environment and reducing microbial load through non-lethal physical action, Prisyna helps manage the symptoms of oral inflammatory conditions and promotes overall oral health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Prisyna.